Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Chemokine inhibition as potential novel therapy for endometriosis, postsurgical adhesions

Oct. 20, 2003

Two series of GSK-3 kinase inhibitors discovered by Lilly researchers

Oct. 20, 2003

Beneficial effects on cholesterol and adiposity for EM-652 in ovariectomized animals

Oct. 17, 2003

Effects of trimegestone/conjugated estrogens in postmenopausal women

Oct. 17, 2003

Benefits reported for a menotropin/follitropin alfa combination in IVF

Oct. 17, 2003

Phase IIb trial of ATL-962 for obesity meets primary endpoint

Oct. 17, 2003

GSK team develops new calcitonin agonists with potential in bone disorders

Oct. 17, 2003

Anti-VE-cadherin antibody blocks folliculogenesis and corpus luteum formation

Oct. 16, 2003

Sodium/glucose cotransporter as a target for the treatment of diabetes

Oct. 16, 2003

JNK pathway as a target for diabetes

Oct. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...